Press Releases

Latest Investor Presentation
More information is coming soon.
Apr 29, 2021
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update Read More
Mar 18, 2021
Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma Read More
Mar 01, 2021
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Read More
Jan 11, 2021
Idera Pharmaceuticals to Present at Upcoming Conferences Read More